Identa AI Stock Analysis
Want to see IDTA full AI Analyst Report?
Identa (IDTA) AI Stock Analysis
Identa
(Other OTC:IDTA)
IDTA's solid score of 78 is primarily driven by its highly attractive valuation and robust technical momentum, with shares trading well above key moving averages. The company's underlying fundamentals provide reliable support, featuring a significantly deleveraged balance sheet and recovering profitability, though historical top-line and cash flow volatility remain a minor tempering factor.
Identa (IDTA) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $930.49K
- Dividend Yield
- ―
- Average Volume (3M)
- 3,326
- Price to Earnings (P/E)
- 6.5
- Beta (1Y)
- -1.56
- Revenue Growth
- 57.25%
- EPS Growth
- ―
- Country
- US
- Employees
- 14
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Specialties
Identa Business Overview & Revenue Model
Company Description
IDenta Corp. operates as a detection and forensic science company. The company offers drug testing kits, explosives testing kits, aero chamber sniffer, forensic, urine drug testing, and saliva drug testing products. It provides its solutions to law e...
How the Company Makes Money
null
Identa Financial Statement Overview
Summary
IDTA exhibits a strong financial foundation highlighted by active debt reduction and a fortified balance sheet. While revenue and cash flow have seen historical volatility, recent trailing-twelve-month results show promising stabilization with expanding net profit margins and positive cash generation.
Income Statement
72PositiveBalance Sheet
86Very PositiveCash Flow
68Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.86M | 1.34M | 1.46M | 1.05M | 1.34M | 1.39M |
| Gross Profit | 958.46K | 686.57K | 756.46K | 662.98K | 983.39K | 1.02M |
| EBITDA | 254.66K | 128.96K | 328.40K | 57.13K | 199.56K | 135.57K |
| Net Income | 141.05K | 99.04K | 258.34K | 14.64K | 162.71K | 69.18K |
Balance Sheet | ||||||
| Total Assets | 2.38M | 1.92M | 1.66M | 1.53M | 1.56M | 1.23M |
| Cash, Cash Equivalents and Short-Term Investments | 669.76K | 379.42K | 735.95K | 264.29K | 368.90K | 347.15K |
| Total Debt | 661.18K | 645.20K | 640.23K | 785.37K | 820.28K | 511.63K |
| Total Liabilities | 1.08M | 1.04M | 921.01K | 1.01M | 1.10M | 799.32K |
| Stockholders Equity | 1.30M | 879.16K | 742.31K | 516.12K | 459.63K | 430.01K |
Cash Flow | ||||||
| Free Cash Flow | 253.53K | 40.28K | 555.85K | -151.97K | 61.56K | -221.97K |
| Operating Cash Flow | 284.25K | 56.94K | 561.89K | -137.63K | 94.31K | -88.95K |
| Investing Cash Flow | -87.01K | -48.05K | -260.40K | -8,154 | -8,611 | -133.02K |
| Financing Cash Flow | 276.22K | -43.78K | -151.47K | -23.53K | -63.95K | 28.02K |
Identa Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IDTA, the sentiment is Negative. The current price of 0.23 is below the 20-day moving average (MA) of 0.31, below the 50-day MA of 0.32, and below the 200-day MA of 0.25, indicating a bearish trend. The MACD of -0.03 indicates Positive momentum. The RSI at 17.59 is Positive, neither overbought nor oversold. The STOCH value of 6.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IDTA.
Identa Peers Comparison
Overall Rating
IDTA78Outperform
BIAF43Neutral
NDRA42Neutral
INBS41Neutral
BNBX38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 78Outperform | $930.49K | 6.46 | 14.16% | ― | 57.25% | ― | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 43Neutral | $3.51M | -0.04 | -331.02% | ― | -18.47% | 87.82% | |
| 42Neutral | $5.88M | -0.77 | -150.38% | ― | ― | 60.87% | |
| 41Neutral | $5.11M | -0.23 | -146.09% | ― | 36.55% | 60.09% | |
| 38Underperform | $470.99K | -0.00 | -337.10% | ― | -27.39% | 99.29% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IDTA | Identa Corp | 0.23 | -0.03 | -11.54% | |
| BNBX | Bnb Plus Corp. | 0.08 | -2.42 | -96.80% | |
| NDRA | Endra Life Sciences | 4.04 | -1.60 | -28.46% | |
| INBS | Intelligent Bio Solutions Inc. | 1.54 | -4.88 | -76.01% | |
| BIAF | bioAffinity Technologies, Inc. | 2.15 | -18.55 | -89.61% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 13, 2026
